A Prospective, Open Label Study of CERtican in KIdney Transplantation

Clinical trial NCT01594268 · COMPLETED

Trial details

NCT number: NCT01594268
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Transplant

Start date: 2012-03-01
Primary completion: 2013-10-01
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.